Europlasma S.A. AI Price Prediction

The reported EPS of -88.61 and a PE ratio of 0.00 indicate that Europlasma S.A. is currently loss‑making and not generating positive earnings to support its valuation. In the absence of evidence of improving profitability or clear revenue growth, the earnings profile points to elevated financial risk and a challenged equity story.

• Negative EPS (-88.61) signals substantial losses per share, implying that the company is far from break-even on a per‑share basis.
• A PE ratio of 0.00 confirms that the market cannot assign a conventional earnings multiple due to the lack of positive net income.
• Without visible profitability or margin data to offset the negative EPS, the financial picture leans toward ongoing operational or structural challenges.

The stock trades at €0.29, down 11.9% over the last month and dramatically below its €15.14 200‑day moving average, indicating a severe long‑term downtrend and likely past value destruction. While the RSI of 18.26 suggests the shares are technically oversold and could experience short‑term bounces, the dominant signal is persistent weakness and negative momentum.

• Current price of €0.29 versus a 200‑day moving average of €15.14 implies an extreme drawdown and entrenched long‑term downtrend, often associated with distressed or heavily diluted equities.
• The recent 11.9% monthly decline reinforces negative price momentum and weak investor confidence in the near term.
• RSI at 18.26 is deeply oversold, which can precede short‑term technical rebounds, but in the context of a major downtrend it more often reflects sustained selling pressure rather than a clear bullish reversal.

Overall, Europlasma S.A.’s stock setup appears bearish: the company is loss‑making, the share price has suffered a severe long‑term decline, and recent performance remains weak. Although the oversold RSI and steady app downloads could support intermittent technical rebounds, they do not outweigh the structural earnings issues and pronounced downtrend.

• Negative earnings, a PE ratio of 0.00, and a price far below the 200‑day moving average collectively signal a high‑risk, distressed equity profile.
• Alternative data are mixed but generally subdued, offering limited evidence of strong underlying business momentum to counteract the negative financial and technical picture.